Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Lung Neoplasms 7 Nasopharyngeal Carcinoma 6 Colorectal Neoplasms 4 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Melanoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Esophageal Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Osteosarcoma 1 Non-squamous Non-small Cell Lung Cancer 1 Neuroblastoma 1 Nasopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Brain Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Colorectal Cancer 1 Adenocarcinoma of Lung 1

Interventions

Cisplatin 28 Radiotherapy 20 pembrolizumab 9 Paclitaxel 9 Surveys and Questionnaires 8 Cetuximab 8 Fluorouracil 7 Docetaxel 7 Radiotherapy, Intensity-Modulated 6 Carboplatin 6 apatinib 5 Low-Level Light Therapy 5 Blood Specimen Collection 5 durvalumab 4 Standard of Care 4 Magnetic Resonance Imaging 4 Gemcitabine 4 Cyclophosphamide 4 Celecoxib 4 Tegafur 3 Radiation 3 Oncolytic Virotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Lidocaine 3 Immunoenzyme Techniques 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Biopsy 3 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Head and Neck Neoplasms × endostar protein × Clear all

NCT03989830 2020-10-23

SLICER

Peking University

Phase 2 Unknown

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡